Noticias de Eulerpool Arbutus Biopharma

Arbutus Biopharma Eulerpool-AFX

Arbutus Biopharma Noticias de Acciones

Arbutus Biopharma es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Arbutus Biopharma.

• 23 de julio ·

  Seeking Alpha
  Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
• 18 de julio ·

  Yahoo
  Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
• 18 de julio ·

  TipRanks
  Arbutus Biopharma Sets Q2 2024 Financial Results Date
• 5 de julio ·

  SeekingAlpha
  Arbutus Biopharma: Focused On HBV With A Potentially Huge Litigation 'Wildcard'
• 5 de julio ·

  SeekingAlpha
  Arbutus Biopharma's IP Legal Wins And Clinical Trials - A Strong Buy Opportunity
• 13 de junio ·

  Yahoo
  Ultragenyx (RARE) Moves 7.8% Higher: Will This Strength Last?
• 10 de junio ·

  TipRanks
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Halozyme (HALO), Arbutus Biopharma (ABUS) and Annexon Biosciences (ANNX)
• 6 de junio ·

  Yahoo
  Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
• 6 de junio ·

  TipRanks
  Arbutus Reports Promising Hepatitis B Trial Results
• 6 de junio ·

  Thefly.com
  Barinthus presents EOT data from Phase 2a trial of imdusiran, VTP-300